Health care stocks were flat to higher premarket Tuesday with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) recently up 0.1%.
Harrow (HROW) shares rose past 24% after the company said it expects revenue for the quarter ended Dec. 31 of between $65 million and $67 million, exceeding analysts' expectations.
STAAR Surgical (STAA) said it has named former chief financial officer Deborah Andrews its interim finance chief, effective immediately. STAAR Surgical shares were up over 2% pre-bell.
Summit Therapeutics (SMMT) said it has appointed Robert LaCaze as chief commercial officer. Summit Therapeutics shares were over 1% higher pre-bell.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。